Yeong-su Jang
Incheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Inhibition of STAT3 signaling induces apoptosis and suppresses growth of lung cancer: good and bad.
Journal: Laboratory animal research
Published: October 14, 2019
A novel STAT3 inhibitor, STX-0119, attenuates liver fibrosis by inactivating hepatic stellate cells in mice.
Journal: Biochemical and biophysical research communications
Published: March 09, 2019
Ninjurin1 Plays a Crucial Role in Pulmonary Fibrosis by Promoting Interaction between Macrophages and Alveolar Epithelial Cells.
Journal: Scientific reports
Published: June 29, 2018
PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer.
Journal: Scientific reports
Published: November 29, 2017
Fermented Pueraria Lobata extract ameliorates dextran sulfate sodium-induced colitis by reducing pro-inflammatory cytokines and recovering intestinal barrier function.
Journal: Laboratory animal research
Published: May 10, 2016
Effective killing of cancer cells and regression of tumor growth by K27 targeting sulfiredoxin.
Journal: Free radical biology & medicine
Published: February 29, 2016
Lactate calcium salt affects the viability of colorectal cancer cells via betaine homeostasis.
Journal: Life sciences
Published: September 07, 2015
Ninjurin1 inhibits colitis-mediated colon cancer development and growth by suppression of macrophage infiltration through repression of FAK signaling.
Journal: Oncotarget
Published: August 26, 2015
Ninjurin1 suppresses metastatic property of lung cancer cells through inhibition of interleukin 6 signaling pathway.
Journal: International journal of cancer
Published: August 21, 2015
Investigation of lactate calcium salt-induced β-catenin destabilization in colorectal cancer cells.
Journal: Life sciences
Published: June 12, 2015
Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL.
Journal: Oncology reports
Published: November 27, 2014
Last Updated: 09/26/2026